|
| Press Releases |
|
 |
|
| Tuesday, October 3, 2023 |
|
|
HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101 |
| more info >> |
|
| Monday, August 28, 2023 |
|
|
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies |
| HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies more info >> |
|
|
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies |
| HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies more info >> |
|
| Monday, July 24, 2023 |
|
|
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the Taiwan Food and Drug Administration (TFDA) has approved its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
|
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the Taiwan Food and Drug Administration (TFDA) has approved its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
| Monday, April 17, 2023 |
|
|
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the US. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
|
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
GEON(R) Performance Solutions Announces Polymax(TPE) Acquisition
Dec 2, 2023 08:00 HKT/SGT
|
|
|
Exosens Signs Partnership With Scientific Imaging Inc.
Dec 2, 2023 08:00 HKT/SGT
|
|
|
BYND Cannasoft Enterprises Inc. announces that it will amend and re-file the Management's Discussion and Analysis for the periods ended June 30, 2023 and September 30, 2023
Dec 2, 2023 06:00 HKT/SGT
|
|
|
UBTECH Passes the Listing Hearing by the Hong Kong Stock Exchange, Sets to Become the "First Listed Company Specialized in Humanoid Robots"
Dec 1, 2023 23:04: JST
|
|
|
「人形机器人第一股」 优必选通过港交所上市聆讯
Dec 1, 2023 21:58 HKT/SGT
|
|
|
「人形機器人第一股」 優必選通過港交所上市聆訊
Dec 1, 2023 21:57 HKT/SGT
|
|
|
UBTECH Passes the Listing Hearing by the Hong Kong Stock Exchange, Sets to Become the "First Listed Company Specialized in Humanoid Robots"
Dec 1, 2023 21:56 HKT/SGT
|
|
|
MedTech Innovations and Digital Breakthroughs: Announcing the 2023 Pharma IT Summit for a Future-Ready Pharmaceutical Landscape
Dec 1, 2023 17:55 HKT/SGT
|
|
|
GC Collaborates with MHI to explore the utilization of hydrogen, ammonia and CCS technology to develop a large-scale petrochemical plant to achieve Net Zero
Dec 1, 2023 17:22 JST
|
|
|
MOU Partnership Signed between Organisers of Bali International Airshow and Angkasa Pura I
Dec 1, 2023 15:30 HKT/SGT
|
|
|
NEC named among IAM's 2023 Asia IP Elite
Dec 1, 2023 14:50 JST
|
|
|
Huatai Securities Becomes First Securities Company in Mainland China to Achieve AA MSCI ESG Rating, Ascending to Global Leadership
Dec 1, 2023 13:26 HKT/SGT
|
|
|
FMC: Film Music Contest & Awards 2023 VIP Artist Travel Stay in Budapest
Dec 1, 2023 11:28 HKT/SGT
|
|
|
AsiaPresswire Bets on AI to Transform PR Distribution Workflows for Singapore's Booming Crypto and DeFi Sector
Dec 1, 2023 09:40: JST
|
|
|
AsiaPresswire押注人工智能改变新加坡加密货币和去中心化金融企业的新闻稿发布工作流程
Dec 1, 2023 09:06 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
